Regulation of the intestinal epithelial barrier by the apical junctional complex

Current Opinion in Gastroenterology

Volumn 22, Issue 2, 2006, Pages 85-89

  Laukoetter, Mike G ^a,b   Bruewer, Matthias ^b   Nusrat, Asma ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Apical junctional complex; Crohn's disease; Cytokines; Epithelia; Inflammatory bowel disease; Intestine

Indexed keywords

CYTOKINE; ENTEROTOXIN; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

BACTERIUM; CELL JUNCTION; CELL MEMBRANE PERMEABILITY; CLOSTRIDIUM PERFRINGENS; CROHN DISEASE; DIARRHEA; ELECTRON MICROSCOPY; EPITHELIUM CELL; GENETIC LINKAGE; HEALTH; HUMAN; INTESTINE EPITHELIUM; PATHOGENESIS; REVIEW; ROTAVIRUS; TIGHT JUNCTION; CYTOLOGY; EPITHELIUM; INTESTINE MUCOSA; METABOLISM; PATHOLOGY;

ADHERENS JUNCTIONS; CROHN DISEASE; CYTOKINES; EPITHELIUM; HUMANS; INTESTINAL MUCOSA; TIGHT JUNCTIONS;

EID: 33745797135     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mog.0000203864.48255.4f     Document Type: Review

References (58)

1. Watson AJ, Chu S, Sieck L, et al. Epithelial barrier function in vivo is sustained despite gaps in epithelial layers. Gastroenterology 2005; 129:902-912. First animal-based real-time study of epithelial architecture, cell shedding process, and barrier function with intact circulation, which shows a sustained epithelial barrier function during cell turnover.
2. Clayburgh DR, Shen L, Turner JR. A porous defense: the leaky epithelial barrier in intestinal disease. Lab Invest 2004; 84:282-291.
3. Kelsall BL, Leon F. Involvement of intestinal dendritic cells in oral tolerance, immunity to pathogens, and inflammatory bowel disease. Immunol Rev 2005; 206:132-148.
4. Kraus TA, Brimnes J, Muong C, et al. Induction of mucosal tolerance in Peyer's patch-deficient, ligated small bowel loops. J Clin Invest 2005; 115:2234-2243.
5. Muller CA, Autenrieth IB, Peschel A. Innate defenses of the intestinal epithelial barrier. Cell Mol Life Sci 2005; 62:1297-1307.
6. Milling SW, Cousins L, MacPherson GG. How do DCs interact with intestinal antigens? Trends Immunol 2005; 26:349-352.
7. Berkes J, Viswanathan VK, Savkovic SD, et al. Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut 2003; 52:439-451.
8. Johansson JE, Brune M, Ekman T. The gut mucosa barrier is preserved during allogeneic, haemopoietic stem cell transplantation with reduced intensity conditioning. Bone Marrow Transplant 2001; 28:737-742.
9. Masuyama A, Kondoh M, Seguchi H, et al. Role of N-terminal amino acids in the absorption-enhancing effects of the c-terminal fragment of Clostridium perfringens enterotoxin. J Pharmacol Exp Ther 2005; 314:789-795.
10. Muza-Moons MM, Schneeberger EE, Hecht GA. Enteropathogenic Escherichia coli infection leads to appearance of aberrant tight junctions strands in the lateral membrane of intestinal epithelial cells. Cell Microbiol 2004; 6:783-793.
11. Chatterjee A, Chaudhuri S, Saha G, et al. Effect of bile on the cell surface permeability barrier and efflux system of Vibrio cholerae. J Bacteriol 2004; 186:6809-6814.
12. Ivanov AI, Nusrat A, Parkos CA. Endocytosis of the apical junctional complex: mechanisms and possible roles in regulation of epithelial barriers. Bioessays 2005; 27:356-365. Extensive summary of endocytic pathways, intracellular destinations and signaling cascades involved in internalization of AJC proteins.
13. Nusrat A, Parkos CA, Verkade P, et al. Tight junctions are membrane microdomains. J Cell Sci 2000; 113 (Pt 10):1771-1781.
14. Heller F, Florian P, Bojarski C, et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 2005; 129:550-564.
15. Conyers G, Milks L, Conklyn M, et al. A factor in serum lowers resistance and opens tight junctions of MDCK cells. Am J Physiol Cell Physiol 1990; 259:C577-C585.
16. Fasano A, Baudry B, Pumplin DW, et al. Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. Proc Natl Acad Sci U S A 1991; 88:5242-5246.
17. Schulzke JD, Gitter AH, Mankertz J, et al. Epithelial transport and barrier function in occludin-deficient mice. Biochim Biophys Acta 2005; 1669:34-42. First animal study aimed at functional characterization of the tight junction protein occludin using an occludin-deficient mouse model.
18. Nusrat A, Brown GT, Tom J, et al. Multiple protein interactions involving proposed extracellular loop domains of the tight junction protein occludin. Mol Biol Cell 2005; 16:1725-1734.
19. Wong V, Gumbiner BM. A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. J Cell Biol 1997; 136:399-409.
20. Wang Z, Mandell KJ, Parkos CA, et al. The second loop of occludin is required for suppression of Raf1-induced tumor growth. Oncogene 2005; 24:4412-4420. A novel study that demonstrates a role of occludin in reversing oncogenesis induced by Raf1.
21. Swisshelm K, Macek R, Kubbies M. Role of claudins in tumorigenesis. Adv Drug Deliv Rev 2005; 57:919-928.
22. Dean P, Kenny B. Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein. Mol Microbiol 2004; 54:665-675.
23. Viswanathan VK, Lukic S, Koutsouris A, et al. Cytokeratin 18 interacts with the enteropathogenic Escherichia coli secreted protein F (EspF) and is redistributed after infection. Cell Microbiol 2004; 6:987-997.
24. Shifflett DE, Clayburgh DR, Koutsouris A, et al. Enteropathogenic E. coli disrupts tight junction barrier function and structure in vivo. Lab Invest 2005; 85:1308-1324.
25. Clark E, Hoare C, Tanianis-Hughes J, et al. Interferon gamma induces translocation of commensal Escherichia coli across gut epithelial cells via a lipid raft-mediated process. Gastroenterology 2005; 128:1258-1267.
26. Van Immerseel F, De Buck J, Pasmans F, et al. Clostridium perfringens in poultry: an emerging threat for animal and public health. Avian Pathol 2004; 33:537-549.
27. Sonoda N, Furuse M, Sasaki H, et al. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: evidence for direct involvement of claudins in tight junction barrier. J Cell Biol 1999; 147:195-204.
28. McClane BA. The complex interactions between Clostridium perfringens enterotoxin and epithelial tight junctions. Toxicon 2001; 39:1781-1791.
29. Nava P, Lopez S, Arias CF, et al. The rotavirus surface protein VP8 modulates the gate and fence function of tight junctions in epithelial cells. J Cell Sci 2004; 117:5509-5519.
30. Coyne CB, Bergelson JM. CAR: a virus receptor within the tight junction. Adv Drug Deliv Rev 2005; 57:869-882.
31. Campbell JA, Schelling P, Wetzel JD, et al. Junctional adhesion molecule a serves as a receptor for prototype and field-isolate strains of mammalian reovirus. J Virol 2005; 79:7967-7978.
32. Leung E, Hong J, Fraser AG, et al. Polymorphisms of CARD15/NOD2 and CD14 genes in New Zealand Crohn's disease patients. Immunol Cell Biol 2005; 83:498-503. Patient-based study with 185 unrelated Caucasian patients with Crohn's disease showing that there is no evidence of CD14-159C/T polymorphism associated with Crohn's disease.
33. Nagy Z, Karadi O, Rumi G, et al. Crohn's disease is associated with polymorphism of CARD15/NOD2 gene in a Hungarian population. Ann N Y Acad Sci 2005; 1051:45-51.
34. Vermeire S, Rutgeerts P. Current status of genetics research in inflammatory bowel disease. Genes Immun 2005; 18 August [Epub ahead of print].
35. Gibson PR. Increased gut permeability in Crohn's disease: is TNF the link? Gut 2004; 53:1724-1725.
36. Hollander D. Permeability in Crohn's disease: altered barrier functions in healthy relatives? Gastroenterology 1993; 104:1848-1851.
37. Yacyshyn BR, Meddings JB. CD45RO expression on circulating CD19+ B cells in Crohn's disease correlates with intestinal permeability. Gastroenterology 1995; 108:132-137.
38. Peeters M, Geypens B, Claus D, et al. Clustering of increased small intestinal permeability in families with Crohn's disease. Gastroenterology 1997; 113:802-807.
39. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347:417-429.
40. Oshitani N, Watanabe K, Nakamura S, et al. Dislocation of tight junction proteins without F-actin disruption in inactive Crohn's disease. Int J Mol Med 2005; 15:407-410.
41. Buhner S, Buning C, Genschel J, et al. Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation? Gut 2005; 29 July [Epub ahead of print].
42. Breslin NP, Nash C, Hilsden RJ, et al. Intestinal permeability is increased in a proportion of spouses of patients with Crohn's disease. Am J Gastroenterol 2001; 96:2934-2938.
43. Pizarro TT, Arseneau KO, Bamias G, et al. Mouse models for the study of Crohn's disease. Trends Mol Med 2003; 9:218-222.
44. Kucharzik T, Walsh SV, Chen J, et al. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am J Pathol 2001; 159:2001-2009.
45. Gassler N, Rohr C, Schneider A, et al. Inflammatory bowel disease is associated with changes of enterocytic junctions. Am J Physiol Gastrointest Liver Physiol 2001; 281:G216-G228.
46. Raddatz D, Bockemuhl M, Ramadori G. Quantitative measurement of cytokine mRNA in inflammatory bowel disease: relation to clinical and endoscopic activity and outcome. Eur J Gastroenterol Hepatol 2005; 17:547-557.
47. Bruewer M, Luegering A, Kucharzik T, et al. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 2003; 171:6164-6172.
48. Wang F, Graham WV, Wang Y, et al. Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol 2005; 166:409-419.
49. Ma TY, Boivin MA, Ye D, et al. Mechanism of TNF-α modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression. Am J Physiol Gastrointest Liver Physiol 2005; 288:G422-G430.
50. Soderholm JD, Streutker C, Yang PC, et al. Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor alpha. Gut 2004; 53:1817-1824.
51. Bruewer M, Utech M, Ivanov AI, et al. Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis- like process. FASEB J 2005; 19:923-933. First study which shows that IFN-γ induces endocytosis of tight junction transmembrane proteins, occludin, JAM-A, and claudin-1 by a macropinocytosis-like process.
52. Utech M, Ivanov AI, Samarin SN, et al. Mechanism of IFN-{gamma} induced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane. Mol Biol Cell 2005; 16:5040-5052. This study dissects the molecular mechanisms of IFN-γ induced endocytosis of epithelial tight junction proteins.
53. Segain JP, Raingeard de la Bletiere D, Sauzeau V, et al. Rho kinase blockade prevents inflammation via nuclear factor kappa B inhibition: evidence in Crohn's disease and experimental colitis. Gastroenterology 2003; 124:1180-1187.
54. Poritz LS, Garver KI, Tilberg AF, et al. Tumor necrosis factor alpha disrupts tight junction assembly. J Surg Res 2004; 116:14-18.
55. Brown SJ, Abreu MT. Antibodies to tumor necrosis factor-alpha in the treatment of Crohn's disease. Curr Opin Drug Discov Devel 2005; 8:160-168.
56. Soderholm JD, Peterson KH, Olaison G, et al. Epithelial permeability to proteins in the noninflamed ileum of Crohn's disease? Gastroenterology 1999; 117:65-72.
57. Ma TY, Iwamoto GK, Hoa NT, et al. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastrointest Liver Physiol 2004; 286:G367-G376.
58. Madara JL. Maintenance of the macromolecular barrier at cell extrusion sites in intestinal epithelium: physiological rearrangement of tight junctions. J Membr Biol 1990; 116:177-184.